The course of psoriasis

Clinics in Dermatology

Volumn 15, Issue 5, 1997, Pages 687-692

  De Jong, Elke M G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CALCITRIOL; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETRETIN; ETRETINATE; FLUOROURACIL; HLA ANTIGEN; INDOMETACIN; LITHIUM; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RETINOID; SALAZOSULFAPYRIDINE; SUBSTANCE P;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; DISEASE COURSE; HEREDITY; HUMAN; ONSET AGE; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; RELAPSE; RELAXATION TRAINING; REMISSION; REVIEW; SUNLIGHT; TOPICAL DRUG ADMINISTRATION;

EID: 0030864014     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(97)00023-0     Document Type: Article

References (75)

1. Glickman FS. Lepra, psora, psoriasis. J Am Acad Dermatol 1986;14:863-6.
2. Hebra F. Psoriasis. In: Atlas der Hautkrankheiten. Vienna: Kaiserliche Akademie der Wissenschaften, 1856-1876:23.
3. Camp RDR. Psoriasis. In: Champion RH, Burton JL, Ebling FJG, editors. Rook/Wilkinson/Ebling: Textbook of dermatology, 5th ed. Oxford: Blackwell Scientific Publications, 1992:1391-1458.
4. Farber EM, Nail ML. The natural history of psoriasis in 5600 patients. Dermatologica 1974;148:1-18.
5. Zachariae H. Epidemiology and genetics. In: Mier PD, van de Kerkhof PCM, editors. Textbook of psoriasis. London: Churchill Livingstone, 1986:4-12.
6. Christophers E, Sterry W. Psoriasis, In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine, 3rd ed. New York: McGraw-Hill, 1993:489-514.
7. Andresen C, Henseler T. Erblichkeit der Psoriasis. Eine Analyse von 1035 Familienanamnesen. Hautarzt 1982;33: 214-7.
8. White S, Newcomer V, Mickey M, et al. Disturbance of HLA-A antigen frequency in psoriasis. New Engl J Med 1972;287:740-3.
9. Russell T, Schultes L, Kuban D. Histocompatability (HL-A) antigens associated with psoriasis. New Engl J Med 1972;287:738-40.
10. Svejgaard A, Nielsen L, Svejgaard E, et al. HL-A in psoriasis vulgaris and in pustular psoriasis-population and family studies. Br J Dermatol 1974;91:145-53.
11. Svejgaard A, Platz P, Ryder L, et al. HL-A and disease associations - a survey. Transplant Rev 1975;22:1-43.
12. Dausset ], Hors J. Some contributions of the HLA complex to the genetics of human disease. Transplant Rev 1975;22: 44-74.
13. Tiwari JL, Lowe NJ, Abramovits J, et al. Association of psoriasis with HLA-DR7. Br J Dermatol 1982;106:227-30.
14. Tomfohrde J, Silverman A, Barnes R, et al. Gene for familial psoriasis susceptibility mapped to the distal end of chromosome 17Q. Science 1994;264:1141-5.
15. Marcusson J, Möller E, Thyresson N. Penetration of HLA-linked psoriasis-predisposing gene(s): A family investigation. Acta Derm Venereol (Stockh) 1976;56:453-63.
16. Buntin DM, Skinner RB, Rosenberg EW. Onset of psoriasis at age 108. J Am Acad Dermatol 1983;9:276-7.
17. Church R. The prospect of psoriasis. Br J Dermatol 1958; 70:139-45.
18. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-6.
19. Melski JW, Stern RS. The separation of susceptibility to psoriasis from age of onset. J Invest Dermatol 1981;77: 474-7.
20. Van de Kerkhof PCM. Clinical features. In: Mier PD, van de Kerkhof PCM, editors. Textbook of psoriasis. London: Churchill Livingstone, 1986:13-39.
21. Durham GA, Morgan JK. A 7-year follow-up study of ninety patients with psoriasis. Br J Dermatol 1974;91:7-11.
22. Telfer NR, Chalmers RJG, Whale K, et al. The role of streptococcali infection in the initiation of guttate psoriasis. Arch Dermatol 1992,128:39-42.
23. Martin BA, Chalmers RJG, Telfer NR. How great is the risk of further psoriasis following a single episode of guttate psoriasis? Arch Dermatol 1996;132:717-8.
24. Moll JMH. Psoriatic arthopathy. In: Mier PD, van de Kerkhof PCM, editors. Textbook of psoriasis. London: Churchill Livingstone, 1986;55-83.
25. Salleras M, Sanchez-Regaña M, Umbert P. Congenital erythrodermic psoriasis: case report and literature review. Pediatr Dermatol 1995;12:231-4.
26. Marrakchi S, Kim I, Delaporte E, et al. Vitamin A and E blood levels in erythrodermic and pustular psoriasis associated with chronic alcoholism. Acta Derm Venereol 1994;74:298-301.
27. Abrahams I, McCarthy JT, Saunders SL. One hundred and one cases of exfoliative dermatitis. Arch Dermatol 1963; 87:96-101.
28. Nicolis GE, Helwig EB. Exfoliative dermatitis: A clinicopathologic study of 135 cases. Arch Dermatol 1973;108: 788-97.
29. Freedberg IM, Baden HP. The metabolic response to exfoliation. J Invest Dermatol 1962;38:277-84.
30. Scher RK. The Nails. In: Roenigk HH Jr, Maibach HI, editors. Psoriasis, 2nd ed. New York: Marcel Dekker, 1991:131-5.
31. Veys EM, Mielants H. Current concepts in psoriatic arthritis. Dermatology 1994;189(suppl 2):35-41.
32. Biondi Oriente C, Scarpa R, Pucino O, et al. Psoriasis and psoriatic arthritis. Dermatological and rheumatological 10-operative clinical report. Acta Derm Venereol Suppl (Stockh) 1989;146(1):69-71.
33. Espinoza LR, Zakhraoui L, Espinoza CG, et al. Psoriatic arthritis. Clinical response and side effects to methotrexate therapy. J Rheumatol 1992;19:872-7.
34. Farr M, Kitas GD, Waterhouse L, et al. Sulphazalazine in psoriatic arthritis: A double-blind placebo-controlled study. Br J Rheumatol 1990;29:46-9.
35. Gupta Ak, Ellis CN, Siegel MT, et al. Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol 1990;126:1516-7.
36. Steinsson K, Jóndsdóttir I, Valdimarsson H. Cyclosporin A in psoriatic arthritis. An open study. Ann Rheum Dis 1990;49:603-6.
37. Hopkins R, Bird HA, Jone H, et al. A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritìs. Ann Rheum Dis 1985;44:189-93.
38. Weber G, Frey H. Treatment of psoriatic arthritis with bromocriptine. J Am Acad Dermatol 1987;16:388-9.
39. 3: A pilot study. Arthritis Rheum 1990;33:1723-7.
40. Dawber RPR, Baran R. Disorders of nails. In: Champion RH, Burton JL, Ebling FJG, editors. Rook/Wilkinson/ Ebling: Textbook of dermatology. 5th ed. Oxford: Blackwell Scientific Publications, 1992:2497-2532.
41. Farber EM, Nail L. Nail psoriasis. Cutis 1992;50:174-8.
42. Tham SN, Lim JJ, Tay SH, et al. Clinical observations on nail changes in psoriasis. Ann Acad Med Singapore 1988; 17:482-5.
43. Scher RK. The nails. In: Roenigk HH, Maibach HI, editors. Psoriasis. 2nd ed. New York: Marcel Dekker, 1990:131-64.
44. Baden HP. Diseases of the hair and nails. 1st ed. Chicago: Year Book Medical Publishers, 1987:48-57.
45. Zaias N. Psoriasis of the nail. A clinical-pathologic study. Arch Dermatol 1969;99:567-9.
46. Hellgren L. Psoriasis. A statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls. Acta Derm Venereol (Stockh) 1964;44:191-207.
47. Molin L. Psoriasis. A study of the course and degree of severity, joint involvement, socio-medical conditions, general morbidity and influences of selection factors among previously hospitalized psoriatics. Acta Derm Venereol Suppl (Stockh) 1972;53(72):1-125.
48. Gunawardena DA, Gunawardena KA, Vasanthanathan NS. Psoriasis on Sri-Lanka a computer analysis of 1366 cases. Br J Dermatol 1978;98:85-96.
49. Scher RK. Psoriasis of the nail. Dermatol Clin 1985;3:387-394.
50. Lavaroni G, Kokelj F, Pauluzzi P, et al. The nails in psoriatic arthritis. Acta Derm Venereol Suppl (Stockh) 186:113.
51. Arnold WP, Gerritsen MJP, van de Kerkhof PCM. Response of nail psoriasis to ciclosporin. Br J Dermatol 1993; 129:750-1.
52. Fritz K. Psoriasis of the nail-successful topical treatment with 5-fluorouracil. Z Hautkrankheiten 1989;64:1083-8.
53. Baran R. Etretinate and the nails (study of 130 cases). Possible mechanisms of some side effects. Clin Exp Dermatol 1986;11:148-152.
54. Van Dooren-Greebe RJ, van de Kerkhof PCM, Chang A, et al. Acitretin monotherapy in the treatment of acrodermatitis continua Hallopeau. Acta Derm Venereol (Stockh)1989;69:344-6.
55. De Jong EMGJ, Seegers BAMPA, Gulinck MK, et al. Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1728 patients. Dermatology 1996; 193:300-4.
56. Janula J, Novotny F. Zur Statistischen Erforschung der Psoriasis. Hautarzt 1965;16:241-6.
57. Yashuda T, Ishikawa E, Moris S. Psoriasis in the Japanese. In: Farber EM, Cox AJ, editors. Psoriasis Proceedings 1st International Symposium. Stanford: Stanford University Press, 1971:25-34.
58. MacLennan A, Hellier FF. The treatment time in psoriasis. Br J Dermatol 1961;73:439-444.
59. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1996;32:982-6.
60. Jowett S, Ryan TJ. Skin disease and handicap: An analysis of the impact of skin conditions. Soc Sei Med 1985;20:425-9.
61. Savin JA. Patients' beliefs about psoriasis. Trans St John's Hosp Dermatol Soc 1970;56:139-42.
62. Braun-Falco O, Burg C, Farber EM. Psoriasis: Eine Fragenbodestudie bei 536 Patienten. Münch Med Wochenschr 1972;114:1-15.
63. Farber EM, Rein G, Lanigan SW. Stress and psoriasis: psychoneuroimmunologic mechanisms. Int J Dermatol 1991;30:8-12.
64. Baughmann R, Sobel R. Psoriasis, stress, and strain. Arch Dermatol 1971;103:599-605.
65. Fava GA, Baldaro B, Osti RMA. Towards a self-rating scale for alexithymia: a report on 150 medical patients. Psychother Psychosom 1980;34:34-9.
66. Invernizzi G, Gala C, Bovio L, et al. Onset of psoriasis: The role of life events. Med Sei Res 1988;16:143-4.
67. Naukkarinen A, Nickoloff BJ, Farber EM. Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 1989;92:126-9.
68. Farber EM, Nickoloff BJ, Recht B, et al. Stress, symmetry, and psoriasis: Possible role of neuropeptides. J Am Acad Dermatol 1986;14:305-11.
69. Zachariae R, Oster H, Bjerring P, et al. Effects of psychologic intervention on psoriasis: A preliminary report. J Am Acad Dermatol 1996;34:1008-15.
70. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
71. Ros AM, Eklund G. Photosensitive psoriasis. J Am Acad Dermatol 1987;17:752-8.
72. Dunna SF, Finlay AY. Psoriasis: improvement during and worsening after pregnancy. Br J Dermatol 1989;120:584.
73. Ikai K. Exacerbation and induction of psoriasis by angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 1995;34:819.
74. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatoi 1987;123:1622-32.
75. Johnson TM, Duvic M, Rapini RP, et al. AIDS exacerbates psoriasis (letter). New Engl J Med 1985;313:1415.